Medicare Enrolled
Dr. Ari Ezratty
Optician · Roslyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ezratty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ezratty?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ezratty
Dr. Ari Ezratty is an optician specialist in Roslyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ezratty performed 9,967 Medicare services across 6,028 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ezratty received a total of $19,016 from 42 pharmaceutical and/or device companies across 933 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ezratty is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in NY
$19,016 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,967
Medicare services
Top 7% in NY for optician
6,028
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~498 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
3,662 | $13 | $52 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,105 | $111 | $442 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
875 | $74 | $270 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
444 | $157 | $692 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
356 | $75 | $313 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
315 | $181 | $689 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
186 | $48 | $178 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
186 | $23 | $84 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
185 | $199 | $817 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
175 | $119 | $447 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
159 | $98 | $394 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
83 | $51 | $198 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $153 | $579 |
| Cardiac catheterization | 75 | $252 | $1,053 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
31 | $530 | $2,159 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
26 | $216 | $853 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
13 | $93 | $341 |
| Tube insertion in bypass graft for diagnosis A tube is inserted into a bypass graft to allow for diagnostic evaluation. A radiologist reviews the procedure. |
13 | $252 | $995 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.5% high complexity
7.0% medium
85.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,016
Total received (2018-2024)
Avg $2,717/year across 7 years
Top 9% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
933
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,016 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,445
2023
$3,226
2022
$3,391
2021
$3,054
2020
$1,702
2019
$2,194
2018
$2,005
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$453
Amgen Inc.
$290
Novartis Pharmaceuticals Corporation
$289
AstraZeneca Pharmaceuticals LP
$266
Boehringer Ingelheim Pharmaceuticals, Inc.
$265
PFIZER INC.
$235
Daiichi Sankyo Inc.
$226
Janssen Pharmaceuticals, Inc
$207
Lexicon Pharmaceuticals, Inc.
$205
Novo Nordisk Inc
$177
Merck Sharp & Dohme LLC
$138
SANOFI-AVENTIS U.S. LLC
$116
Esperion Therapeutics, Inc.
$88
Abbott Laboratories
$86
Boston Scientific Corporation
$80
HEARTFLOW, INC.
$53
Chiesi USA, Inc.
$53
Kiniksa Pharmaceuticals International, plc
$52
Regeneron Healthcare Solutions, Inc.
$49
Bayer Healthcare Pharmaceuticals Inc.
$48
Inspire Medical Systems, Inc.
$42
Baxter Healthcare
$27
Top 3 companies account for 30.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,172
AstraZeneca Pharmaceuticals LP
$2,113
Janssen Pharmaceuticals, Inc
$1,529
Novartis Pharmaceuticals Corporation
$1,448
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,441
E.R. Squibb & Sons, L.L.C.
$1,282
PFIZER INC.
$1,003
SANOFI-AVENTIS U.S. LLC
$913
Abbott Laboratories
$761
Esperion Therapeutics, Inc.
$724
Merck Sharp & Dohme LLC
$615
Bayer HealthCare Pharmaceuticals Inc.
$484
Chiesi USA, Inc.
$439
Novo Nordisk Inc
$426
Regeneron Healthcare Solutions, Inc.
$381
Boston Scientific Corporation
$336
NOVARTIS PHARMACEUTICALS CORPORATION
$317
Daiichi Sankyo Inc.
$255
Lexicon Pharmaceuticals, Inc.
$251
ARBOR PHARMACEUTICALS, INC.
$249
Kowa Pharmaceuticals America, Inc.
$239
Althera Pharmaceuticals LLC
$223
Merck Sharp & Dohme Corporation
$204
ABIOMED
$148
Medtronic Vascular, Inc.
$105
Bayer Healthcare Pharmaceuticals Inc.
$101
Relypsa, Inc.
$89
Kestra Medical Technology Services, Inc.
$84
Gilead Sciences, Inc.
$81
Kiniksa Pharmaceuticals, Ltd.
$80
BOSTON SCIENTIFIC CORPORATION
$69
Inspire Medical Systems, Inc.
$62
Allergan Inc.
$61
HEARTFLOW, INC.
$53
Kiniksa Pharmaceuticals International, plc
$52
CHIESI USA, INC.
$52
CSL Behring
$45
Lundbeck LLC
$34
Baxter Healthcare
$27
Impulse Dynamics (USA) Inc.
$24
HeartFlow, Inc.
$23
Otsuka America Pharmaceutical, Inc.
$20
Top 3 companies account for 30.6% of all-time payments
Associated products mentioned in payments ›
AVEIR · Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · CAMZYOS · CHANTIX · CLEVIPREX · CardioMEMS HF System · Corlanor · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · FARXIGA · FFRct · GALLANT · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · INSPIRE · Impella · Inpefa · JARDIANCE · KENGREAL · KENGREAL 50MG/10ML L · Kcentra · Kerendia · LEQVIO · LIVALO · LOKELMA · Livalo · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · Optimizer Smart System · Ozempic · PERCLOSE PROSTYLE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Quadra Assura CRT Defibrillator · Ranexa · Repatha · Resolute · Roszet · Rybelsus · SAMSCA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VYNDAQEL · Veltassa · Verquvo · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · XIENCE SIERRA · Xience Sierra Coronary Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for optician in NY.
Geographic Context
Opticians within 10 mi
16,372
Per 100K population
1179.4
County median income
$143,408
Nearest hospital
ST FRANCIS HOSPITAL - THE HEART CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ezratty is a clinical cardiology specialist, with above-average Medicare volume (top 7% in NY), with low-engagement industry engagement in the top 9% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ezratty experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Ezratty performed 3,662 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ezratty receive payments from pharmaceutical companies?
Yes. Dr. Ezratty received a total of $19,016 from 42 companies across 933 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ezratty's costs compare to other opticians in Roslyn?
Dr. Ezratty's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ezratty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Roslyn
Browse opticians in Roslyn ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology